Discounted Cash Flow Rating

Buy

Return on Equity Rating

Buy

Debt to Equity Rating

Buy

Price to Earnings Rating

Strong Buy

Analyst Rating

Strong Buy

Upgrade To View Simple Moving Average Rating

Upgrade

Upgrade To Get Access

Upgrade To View Exponential Moving Average Rating

Upgrade

Upgrade To Get Access

Upgrade To View Relative Strength Index Rating

Upgrade

Upgrade To Get Access

Upgrade To View Standard Deviation Rating

Upgrade

Upgrade To Get Access

Upgrade To View Williams %R Rating

Upgrade

Upgrade To Get Access

Upgrade To View Average Directional Index Rating

Upgrade

Upgrade To Get Access

Upgrade To View Insider Trading Rating

Upgrade

Upgrade To Get Access

Wall Street Data Solutions Rating

Neutral

B

Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP)

Pharmaceutical Preparations

https://www.horizontherapeutics.com

Horizon Therapeutics PLC is a biotechnology company. The company is focused on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. Some of its pipeline products include UPLIZNA; HZN-825; Dazodalibep; Daxdilimab; TEPEZZA and others.

Current Price

---.--

% Change Today

0.00%

Change Amt. Today

0.00

Active Status

Active

Listing Date

07/28/2011

Market Cap

N/A

Shares Outstanding

229,000,000

Weighted SO

228,994,568

Total Employees

N/A

Upcoming Earnings

N/A

Similar Tickers

BMY --.--%

ABBV --.--%

MRK --.--%

GILD --.--%

JNJ --.--%

AMGN --.--%

LLY --.--%

AZN --.--%

SNY --.--%

Beta

1.0114

Last Div

0.0000

Range

60.03-116.38

Chg

0.0500

Avg Vol

2848479

Mkt Cap

N/A

Exch

NASDAQ

Country

IE

Phone

353 1 772 2100

DCF Diff

26.5802

DCF

84.0498

Div Yield

0.0000

P/S

0.0000

EV Multiple

0.1364

P/FV

5.0090

Div Yield %

0.0000

P/E

88.0413

PEG

-23.1842

Payout

0.0000

Current Ratio

4.2738

Quick Ratio

3.5022

Cash Ratio

2.6857

DSO

96.3048

DIO

92.8849

Op Cycle

189.1897

DPO

46.6500

CCC

142.5397

Gross Margin

0.7538

Op Margin

0.1297

Pretax Margin

0.1136

Net Margin

0.1111

Eff Tax Rate

0.0214

ROA

0.0325

ROE

0.0586

ROCE

0.0421

NI/EBT

0.9786

EBT/EBIT

0.8753

EBIT/Rev

0.1297

Debt Ratio

0.2750

D/E

0.4815

LT Debt/Cap

0.3237

Total Debt/Cap

0.3250

Int Coverage

7.6356

CF/Debt

0.2636

Equity Multi

1.7509

Rec Turnover

3.7901

Pay Turnover

7.8242

Inv Turnover

3.9296

FA Turnover

7.5044

Asset Turnover

0.2924

OCF/Share

2.9473

FCF/Share

2.4896

Cash/Share

10.9140

OCF/Sales

0.2479

FCF/OCF

0.8447

CF Coverage

0.2636

ST Coverage

42.1363

CapEx Coverage

6.4390

Div&CapEx Cov

6.4390

P/BV

5.0090

P/B

5.0090

P/S

0.0000

P/E

88.0413

P/FCF

0.0000

P/OCF

39.4595

P/CF

39.4595

PEG

-23.1842

P/S

0.0000

EV Multiple

0.1364

P/FV

5.0090

DPS

0.0000

Latest Headlines (EST)

No Headlines Found

Revenue Product Segmentation